marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Esperion Therapeutics Financial Ratios 2011-2024 | ESPR
Annual Financial Ratios Esperion Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.4 | -1.6 | -0.4 | -5.9 | -15.2 | -6.0 | -10.3 | -3.3 | -6.6 | -20.7 | -4.9 | - | - |
P/S |
2.6 | 5.1 | 1.5 | 3.7 | 10.0 | - | - | - | - | - | - | - | - |
EPS |
-2.0 | -3.5 | -9.3 | -5.2 | -3.6 | -7.5 | -7.0 | -3.3 | -2.3 | -2.2 | -3.3 | -36.3 | -36.2 |
EV (Enterprise Value) |
877 M | 829 M | 488 M | 991 M | 1.51 B | 1.24 B | 1.71 B | 228 M | 259 M | 676 M | 76 M | 18.2 M | 6.67 M |
EBITDA per Share |
-1.51 | -2.7 | -7.82 | -4.5 | -3.42 | -7.64 | -7.05 | -3.37 | -2.26 | -2.2 | -2.88 | - | - |
EV/EBITDA |
-2.1 | -6.0 | -14.2 | -5.7 | -10.0 | -2.8 | -5.1 | -18.6 | -3.2 | - | - | ||
PEG |
0.12 | 1.15 | -0.01 | 0.12 | -0.29 | 0.75 | 0.09 | 0.07 | 3.65 | -0.63 | -0.06 | - | - |
P/B |
-0.7 | -1.2 | -0.6 | -8.8 | 74.2 | 15.3 | 7.0 | 1.1 | 1.1 | 5.6 | 1.7 | - | - |
P/CF |
-2.2 | -2.2 | -0.4 | -8.6 | -20.8 | -8.1 | -13.1 | -5.2 | -8.5 | -22.8 | -7.1 | - | - |
ROE % |
45.99 | 72.17 | 136.64 | 149.32 | -487.04 | -255.07 | -68.24 | -32.80 | -17.33 | -27.24 | -35.21 | - | - |
ROA % |
-101.68 | -94.24 | -70.52 | -40.64 | -45.31 | -140.68 | -60.10 | -30.58 | -16.84 | -25.38 | -33.32 | - | - |
ROCE % |
34.19 | 55.44 | 115.12 | -46.84 | -62.75 | -258.58 | -69.06 | -33.16 | -17.26 | -26.28 | -30.72 | - | - |
Current Ratio |
0.3 | 0.4 | 0.7 | 3.7 | 3.2 | 2.2 | 6.2 | 13.7 | 38.1 | 19.4 | 14.4 | - | - |
DSO |
129.0 | 137.0 | 53.4 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | 2462.2 | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 7931.0 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
129.0 | 137.0 | 53.4 | 2462.2 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
129.0 | 137.0 | 53.4 | -5468.7 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Esperion Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.15 | -0.33 | 0.36 | -0.37 | -0.46 | -0.79 | - | -0.81 | -1.05 | -0.93 | - | -2.62 | -1.67 | -3.5 | -3.89 | -3.07 | 4.5 | -2.84 | -2.26 | -2.52 | -2.01 | 3.26 | -2.24 | -1.86 | -1.71 | -1.73 | -1.44 | -1.86 | -1.92 | -1.8 | -1.29 | -0.77 | -0.62 | -0.65 | -0.58 | -0.57 | -0.55 | -0.56 | -0.49 | -0.64 | -0.6 | -0.51 | -0.63 | -0.34 | -19.82 | -12.24 | -8.12 | -10.31 | -9.94 | -7.96 | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | -0.62 | - | -0.61 | -0.83 | -0.7 | - | -2.09 | -1.24 | -3.18 | -3.56 | -2.88 | 4.68 | -2.7 | -2.15 | -2.41 | -2.05 | 3.24 | -2.26 | -1.88 | -1.73 | -1.76 | -1.48 | -1.87 | -1.93 | -1.81 | -1.3 | -0.78 | -0.63 | -0.65 | -0.59 | -0.57 | -0.55 | -0.55 | -0.49 | -0.62 | -0.6 | -0.51 | -0.63 | -0.35 | -12.1 | -9.56 | -6.32 | -8.87 | -8.76 | -7.11 | - | - | - | - |
ROE % |
15.29 | 20.74 | 21.47 | 60.95 | 69.63 | 78.94 | 64.26 | 83.39 | 83.78 | 75.39 | 67.24 | 175.91 | 245.66 | 101.68 | 149.32 | -269.86 | -701.47 | -843.64 | -487.04 | -252.42 | 27.24 | 241.22 | -255.07 | -194.67 | -150.07 | -109.98 | -68.24 | -65.43 | -54.56 | -42.99 | -32.80 | -24.70 | -21.54 | -19.72 | -17.33 | -19.84 | -22.73 | -25.33 | -27.24 | -33.23 | -32.96 | -35.39 | -35.21 | -15.42 | -0.25 | 16.74 | 22.47 | 15.76 | 7.65 | - | - | - | - | - |
ROA % |
-29.26 | -41.14 | -48.07 | -82.05 | -81.03 | -76.29 | -50.71 | -81.52 | -78.15 | -93.72 | -79.01 | -108.59 | -101.97 | -51.12 | -40.64 | -39.95 | -47.65 | -108.21 | -45.31 | -58.28 | -61.18 | -67.78 | -140.68 | -112.47 | -93.95 | -77.67 | -60.10 | -58.27 | -49.10 | -39.22 | -30.58 | -23.21 | -20.44 | -18.91 | -16.84 | -19.00 | -21.52 | -23.77 | -25.39 | -31.16 | -31.01 | -33.40 | -33.32 | -58.90 | -98.04 | -132.50 | -127.08 | -89.13 | -43.30 | - | - | - | - | - |
ROCE % |
-14.26 | -8.63 | 6.87 | 45.57 | 53.01 | 61.00 | 49.37 | 64.74 | 65.96 | 58.69 | 56.80 | 156.22 | 224.64 | 79.58 | 126.28 | -268.69 | -682.15 | -824.97 | -466.67 | -247.77 | 17.99 | 236.42 | -258.58 | -197.74 | -152.52 | -111.62 | -69.06 | -66.06 | -55.11 | -43.54 | -33.31 | -25.11 | -21.86 | -19.93 | -17.42 | -19.84 | -22.60 | -25.19 | -27.12 | -33.24 | -33.28 | -32.11 | -30.72 | -12.36 | 2.17 | 14.86 | 19.37 | 14.15 | 6.92 | - | - | - | - | - |
Current Ratio |
0.5 | 0.5 | 0.6 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | - | 0.6 | 0.7 | 0.4 | 0.5 | 0.5 | 0.8 | 0.8 | 0.8 | 0.8 | 1.1 | 1.1 | 1.1 | 1.1 | 2.2 | 2.2 | 2.2 | 2.2 | 8.4 | 8.4 | 8.4 | 8.4 | 14.8 | 14.8 | 14.8 | 14.8 | 35.6 | 35.6 | 35.6 | 35.6 | 14.7 | 14.7 | 14.7 | 14.7 | 18.6 | 18.6 | 18.6 | 18.6 | 0.3 | 0.3 | 0.3 | - | - | - | - | - |
DSO |
113.3 | 71.0 | 32.2 | 112.0 | 136.6 | 131.5 | - | 75.7 | 60.8 | 116.4 | - | 137.9 | 43.9 | 169.5 | 117.3 | 294.9 | 5.3 | 307.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
113.3 | 71.0 | 32.2 | 112.0 | 136.6 | 131.5 | - | 75.7 | 60.8 | 116.4 | - | 137.9 | 43.9 | 169.5 | 117.3 | 294.9 | 5.3 | 307.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
113.3 | 71.0 | 32.2 | 112.0 | 136.6 | 131.5 | - | 75.7 | 60.8 | 116.4 | - | 137.9 | 43.9 | 169.5 | 117.3 | 294.9 | 5.3 | 307.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency